2.47
2.37%
-0.06
前日終値:
$2.53
開ける:
$2.5802
24時間の取引高:
14,969
Relative Volume:
0.23
時価総額:
$2.61M
収益:
-
当期純損益:
$-11.66M
株価収益率:
-0.2432
EPS:
-10.156
ネットキャッシュフロー:
$-11.09M
1週間 パフォーマンス:
+11.76%
1か月 パフォーマンス:
-21.09%
6か月 パフォーマンス:
-64.81%
1年 パフォーマンス:
-70.47%
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
名前
Phio Pharmaceuticals Corp
セクター
電話
(508) 767-3861
住所
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
PHIO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
PHIO | 2.47 | 2.61M | 0 | -11.66M | -11.09M | -10.16 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2020-08-05 | 開始されました | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp (PHIO) 最新ニュース
Phio Pharmaceuticals Announces Completion of Enrollment in Second - The Kingston Whig-Standard
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile
Phio Pharmaceuticals Corp. (PHIO) Quarterly 10-Q Report - Quartzy
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Alberta Daily Herald Tribune
Phio Pharma Reports 100% Tumor Clearance in Phase 1b Trial, Cuts Q3 Net Loss by 46% | PHIO Stock News - StockTitan
Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
PHIO stock touches 52-week low at $2.38 amid market challenges - Investing.com
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Quantisnow
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan
Phio Pharmaceuticals presents novel cancer therapy data - Investing.com
Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Newsfile
Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - MSN
Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile
Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 2.5% – Time to Sell? - Defense World
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference - Yahoo Finance
Nu Holdings Ltd Cl A (NU-N) QuotePress Release - The Globe and Mail
This trade activity should not be overlooked: Hyliion Holdings Corporation (HYLN) - SETE News
INTASYL Technology and Compounds to be Focus of Presentation at 20th - North Bay Nugget
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society - Newsfile
HITE Hedge Asset Management LLC Sells 12,931 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail
Hyliion Holdings Corporation (HYLN) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat
Financial Metrics Unveiled: P3 Health Partners Inc (PIII)’s Key Ratios in the Spotlight - The Dwinnex
Does Hyliion Holdings Corporation (NYSE: HYLN) Still Need To Convince Analysts? - Stocks Register
Barrow Hanley Mewhinney & Strauss LLC Purchases Shares of 898,419 Helios Technologies, Inc. (NASDAQ:HLIO) - MarketBeat
Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World
King Luther Capital Management Corp Boosts Position in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Texas Permanent School Fund Corp Has $1.39 Million Stock Holdings in PHINIA Inc. (NYSE:PHIN) - Defense World
Thailand's new celebrity baby pygmy hippo, Moo Deng - The Business Standard
Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World
American Century Companies Inc. Raises Position in PHINIA Inc. (NYSE:PHIN) - Defense World
Phio Pharmaceuticals Corp (PHIO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):